A B S T R A C T The sera of four patients with chronic hemolytic anemia due to cold agglutinins deposited C' globulins on normal red cells at 370C. The circulating cells of the patients were heavily coated with C' complex and were relatively resistant to C' hemolysis by cold agglutinin. Such red cells were removed from the patients' circulation at an exponential rate with 51Cr tj that varied from 7 to 19 days. Normal red cells were removed rapidly by hepatic sequestration during the first hours in the patients' circulation. Thereafter, a slower rate of abnormal destruction occurred which was associated with the accumulation of C' complexes on the red cell and the development of resistance to C' hemolysis by cold agglutinin. Normal red cells coated with sufficient C' complex by action of cold agglutinins in vitro to produce resistance to C' hemolysis by cold agglutinins demonstrated varying degrees of improved survival during the first hours in the circulation of three of the patients.
The levels of serum C' were reduced in all four patients with chronic hemolytic anemia due to cold agglutinins. Transfusion of large volumes of normal red cells into two patients further reduced serum C'. 51Cr-labeled normal red cells survived longer after red cell transfusions than before, because of less rapid destrction during the first hours in the circulation. The reduction in serum C' levels appeared responsible for the improved survival.
INTRODUCTION
The hemolytic anemia associated with high titers of anti-I cold agglutinins is sometimes intermittent, with acute episodes of hemolysis after exposure to low temperatures. In the majority of our patients abnormal blood destruction has been chronic and independent of reduction in body temperature. It is probable that the episodes of hemoglobinuria that follow chilling in some patients are due to complement (C') hemolysis by these macroglobulin antibodies which have hemolytic as well as agglutinating properties (1) . The patients with the chronic form of hemolytic anemia which we have studied have not manifested hemoglobinuria when exposed to low temperatures, despite the occurrence of acrocyanosis secondary to intravascular agglutination. There are two features of the disease in such patients which appear to prevent acute hemolysis. Serum C' values are usually low and the circulating red cells are abnormally resistant to C' hemolysis in vitro by anti-I cold agglutinins.'
In a preceding report we have presented evidence that accumulation of C' globulins by the red cell resulting from repeated transient reactions with cold agglutinin at body temperature is the principal cause of the resistance of the patients' red cells to C' hemolysis in the chronic form of the disease (2) . Data presented here indicate that incomplete C' complexes, which accumulate on the circulating red cells at normal body temperatures, protect red cells from rapid destruction by C' and cold agglutinin, but lead to a more gradual removal in which splenic sequestration may predominate.
METHODS

Patient material
Studies of four patients with chronic hemolytic anemia associated with cold agglutinins with anti-I specificity are reported. The basic hematologic and serologic data appear in Table I . Case 1. E. M., a 60-yr-old male with high titers of cold agglutinin, has been reported on previously (3) . Splenectomy in August 1962 was followed by improvement in hematocrit for 18 months. The patient's red cells, which had exhibited relatively normal morphology and hypotonic fragility before splenectomy, developed spherocytosis and a marked increase in hypotonic fragility. After this period of improvement a gradual fall in hematocrit began. 1 yr later, after prolonged exposure to cold, he was readmitted with gangrene of both lower extremities. Studies reported here were carried out after the onset of relapse, before and after recovery from bilateral below-the-knee amputations.
Case 2. A. J., an 81 yr old woman, had noted acrocyanosis for 3 yr but never observed change in color of the urine after chilling. Her symptoms remained much the same during the 3 yr before the study but her cold agglutinin titer had increased from 1: 32,000 to 1: 200,000. Physical examination was without significant abnormalities. Case 3. 0. A., a 76 yr old man, noted cyanosis and pain in his fingers and toes during exposure to cold in 1955. These symptoms increased gradually until, in 1964, the hematocrit was 34%, reticulocytes were 4%o, the serum bilirubin was elevated, and cold agglutinins were present in high titer. The patient then received 10 mg of Chlorambucil daily for 4 months. This was discontinued Case 4. B. C., a 73 yr old man who had been losing weight for 1 yr, developed symptoms of gall bladder disease and underwent cholecystectomy. At that time he was anemic and was found to have cold agglutinins. There was no adenopathy and liver and spleen were not palpable.
The first three patients had high titers of cold agglutinins associated with acrocyanosis. The fourth had lower levels of cold agglutinins and had not noted acrocyanosis. The cold agglutinins of all four patients produced C' hemolysis of normal cells at 30°C; the cold agglutinins of two (E. M. and A. J.) were hemolytic at 37'C within a pH range of 7.2-7.4. The sera of all four deposited C' globulins on normal red cells at 37'C even though C' hemolysis was not produced at this temperature by the sera of two (0. A. and B. C.).
The red cells of all four patients washed at 37'C were agglutinated by antiglobulin serum with anti-p13 (C'3) and anti-,8de (C'4) activity (2, 4, 5) . Agglutination was not produced by antisera with anti-yG and anti--yM activity. The adsorption of "MI-labeled anti-f3-globulin serum was always three to four times that adsorbed by normal red cells and within the same range as normal red cells that had been reacted with cold agglutinin and C' so as to produce accumulation of C' globulins (2). The patients' red cells were resistant to C' hemolysis by cold agglutinins at 25'C within the pH range of 7.2-7.4, and although slight C' hemolysis occurred at pH 6. 8, the 
Experimental methods
The techniques employed in the isolation and study of radioiodinated cold agglutinin have been described elsewhere (1) .
Coating of normal cells with C' globulins. The methods used to accumulate C' complex on normal cells by action of cold agglutinin are described in a report on the in vitro studies of the resistance of such cells to C' hemolysis by cold agglutinins (2) . The same technique has been employed under sterile conditions to coat normal cells with C' complex for in vivo survival studies. In later experiments, it was demonstrated that the plasma of E. M. collected in acid citrate dextrose (ACD) solution in the proportion of 10 paris whole blood to 1 part ACD could be used as the source of cold agglutinin with production of only 1-2%o C' hemolysis during the coating of normal cells. The plasma was mixed with 3 volumes of normal serum, and 1 volume of normal cells was suspended in an equal volume of the serum plasma mixture. The reagents were mixed at 370C and then cooled to 250C. The temperature was again raised to 370C. Alternation of temperature was accomplished five times in 30 min. At the end of 30 min, the cells were sedimented at 370C and the mixture of plasma and normal serum was replaced. This procedure was repeated for 3 hr. The degree of hemolysis was measured by comparing the amount of hemoglobin in the supernatant fluid with 100% hemolysis of an equal volume of red cells. The coated red cells, normal red cells, and the red cells of the patients were tested for susceptibility to C' hemolysis by cold agglutinin as described below. Red cells coated with C' complex in vitro by action of cold agglutinin and normal serum will be referred to as C'1423 cells though it is recognized that other fractions of C' globulins may also be present (2).
Anti-,8-globulin serum. The production and testing of antisera for human C' globulins, as well as the radioiodination of the antisera and its use in measuring C' globulins on normal cells, have been described elsewhere (2) . The adsorption of radioiodinated anti-8-globulin serum by red cells of patients is compared with the adsorption of the antiserum by normal cells and expressed as the ratio of radioactivity of patients' cells to normal cells. Red cells from patients with hemolytic disorders not associated with immunological abnormalities adsorbed the same amount of 'I activity as normal red cells.
C' hemolysis by cold agglutinin. 0.1 ml of cells was suspended in 1 ml of a mixture of 1 part patient's serum containing cold agglutinins and 3 parts normal serum.
The sera had been adjusted to pH 7.2 or 6.8 by addition of mineral acid. The cell serum suspension was mixed at 37°C and then incubated at 250C, or at a higher temperature if so designated. After 30 min the hemoglobin concentration was compared to that produced by 100% osmotic hemolysis of an aliquot of the same suspension.
When 'Cr-labeled cells were present, the percentage hemolysis of these cells was determined by comparing the 51Cr counts in the supernatant hemolysate with the total 5'Cr counts of the specimen.
Titration of serum complement. The titration of human complement was performed by the method of Ecker, Pillemer, and Seifter (6) . 51Cr labeling of normal and C'-coated red cells. 10 ml of whole blood was collected with 2.0 ml of ACD solution which served as anticoagulant and a medium to hasten the labeling of red cells by 51Cr (7) . 100 ,uc of 5'Cr as Na2CrO was added to the blood with constant agitation.
The final concentration of the chromium salt was less than 2.0 ,ug/ml of blood (8) . The There was slight parallel increase in both spleenprecordium and liver-precordium ratios in A. J., whereas the spleen-precordium ratios increased significantly in B. C. Despite the relatively low titer of cold agglutinins in the latter patient, the tj of 7 days exceeded the rate of removal of autologous cells of any other patient in the series.
Survival in patients of normal red cells and normal red cells coated with C' complex in vitro.
When 51Cr-labeled group 0 I-positive cells from a normal donor were given to E. M. (case 1) the rate of removal was rapid. About 50% of the red cells remaining in the circulation 5 min after injection was removed at the end of 1 hr. The rate of disappearance then diminished and the remaining cells were removed at an exponential rate with a tj of 12-14 days (Fig. 1) . A week later, cells from this donor were coated with C' globulins by incubation with cold agglutinin and whole serum. Approximately 7% hemolysis had occurred during the 3 hr of incubation. The residual cells were resistant to C' hemolysis by cold agglutinins and showed a slight increase in hypotonic fragility. The survival of the C'1423 cells is compared with the survival of the normal cells and survival of autologous cells in Fig. 1 .
After injection of the normal red cells 10% of the 51Cr counts present in whole blood at 5 mm was in the plasma as opposed to 1.5%o with C'1423 cells. Blood volume determinations based on the 5-min 51Cr counts of whole blood were 3200 and 3500 ml for the normal and C'1423 cells respectively. The higher plasma counts after the injection of normal red cells indicate that appreciable intravascular hemolysis occurred without clearance of the 51Cr, though some of the plasma counts may have been contributed by C' hemolysis during collection before mixing with EDTA.
This experiment was repeated 7 months later when the hematological status was unchanged. C'1423-coated cells from the donor used in the previous experiment were administered before the normal cells. The survival curves of each were approximately the same as those shown in Fig. 1 . (case 3) . 30%o of the counts present at 5 min was removed at the end of 2 hr. Thereafter, the rate of removal was relatively slow but continued to be abnormal with a t4 of 10 days. At a later date, 51Cr-labeled C'1423-coated cells from the same donor were injected. 20%o of C'1423 cells was removed at the end of the first 2 hr. Thereafter, the rate of removal approximated the removal of the normal cells. The tj survival was also 10 days. The ratios of liver-precordium and spleen-precordium counts during the two observations of red cell survival in case 3 are shown in Fig. 3 . During the initial period of removal of the normal cells the liver-precordium ratio increased rapidly. When C'1423 cells were injected the liverprecordium ratio did not increase, a finding which suggests a different mechanism of removal.
Survival of 51Cr-labeled cells before and after administration of red cells from 2 U of blood. Previous observations had indicated discrepancies in the rate of destruction of transfused cells in case 1. 51Cr-labeled normal cells had been removed rapidly with a half-life of less than 24 hr; yet red cell transfusions were given without reactions and the half-life of these cells was measured on one occa- sion by the Ashby technique to be 19 days or roughly one-third normal. This finding suggested that the mechanism for removal of normal cells by cold agglutinin was limited and that the rapid removal of 51Cr-labeled cells might not occur after the administration of 500 ml of red cells.
5 ml of red cells was removed from each of 2 pints of group 0 I-positive blood within 4 hr of withdrawal from the donors. The cells were labeled with 51Cr and injected into the patient. 48%o of the counts present at 5 min was removed from the circulation at 30 min and 52% was removed in 16 hr. During the next 6 hr, a small but significant rise in counts occurred, indicating that some sequestered cells had been returned to the circulation. An additional 5 ml of cells was removed from each of the 2 pints of blood for 51Cr labeling. The remaining cells, washed to remove C', were administered without incident. After completion of the transfusion, the second suspension of 51Cr-labeled cells was injected. If one assumes that the 51Cr-labeled cells already present in the circulation were now being removed at the constant rate observed after 24 hr in previous studies, one may calculate the survival of this second suspen- sion of 51Cr-labeled cells given after the transfusion. 13%o of the counts present at 5 min was removed at 30 min and 23%7o was removed at 16 hr.
Thereafter, the rate of removal was more gradual with a tj of 10 days (Fig. 4) .
The above observation was repeated at a later date except that the initial survival curve was observed for 3 days to record the beginning of the period of more gradual destruction after the first 24 hr (Fig. 4) . The initial rate of removal of the pretransfusion 51Cr-labeled cells was again rapid, with 46%o removal in 1 hr followed by a return of some cells to the circulation at the end of 24 hr. The gradual slope of red cell removal then began. After transfusion of approximately 400 ml of red cells, the second aliquot of 51Cr-labeled cells was given. Initial destruction was more gradual in that 2%o of the counts was removed at 40 min and 12%o was removed at 3 hr.
Similar studies were carried out with case 2. After completion of a survival study of group 0 I-positive cells in the patient, she received group A I-positive cells from 2 pints of blood. A second survival study of the normal group 0 I-positive cells was begun promptly thereafter. As shown in Fig. 5 , there was only a slight decrease in the rate of removal of group 0 cells. There was no evidence of isoimmunization to the red cells of this group 0 donor and when cells from this donor were coated with C' complex before injection they showed the improved survival depicted in Fig. 2 .
A second study was carried out with group A I-positive red cells. The red cells of this donor were found in many in vitro observations to be less susceptible to C' hemolysis by cold agglutinin than the group 0 cells used in the previous observation. The rate of removal of the group A cells was less rapid (Fig. 5) lating cells in anti-fl-globulin serum was again complete. Levels of serum C' were measured before and after transfusions of red cells in 10 patients with a variety of hematologic disorders. Change in C'H50 units varied between + 3 and -14% with an average change of -3%.
Development of resistance to heMolysis of 5'Crlabeled cells in vivo. The susceptibility of 51Cr-labeled group A I-positive red cells to complement hemolysis after their introduction into the circulation of case 2 was studied by determining the percentage hemolysis of the 51Cr-labeled cells compared with the hemolysis of samples of the total cell population.
4 ml of red cells of a normal group A donor was labeled with 51Cr and transfused into the patient. The time of withdrawal of the sample, the per cent hemolysis of the cell suspension, and the per cent hemolysis of the 51Cr-labeled cells are presented in Table V . The 51Cr-labeled cells were susceptible to C' hemolysis by cold agglutinin after injection, but acquired resistance during -the first few hours. After 24 hr the hemolysis of the transfused group A I-positive cells had decreased from 53 to 17%, even though 72% of the labeled red cells remained in the circulation. The pH of 6.8 and temperature of 250C were selected in order to produce maximum hemolysis of the patient's cells as well as of the injected 51Cr-labeled cells. These observations were repeated at a later date with similar results. DISCUSSION Consistent with observations of others, the red cells of the four patients with chronic hemolytic anemia due to cold agglutinins were agglutinated by antisera containing anti-,l81-or anti-Pfle-activity (4, 5) . There is evidence that the intensity of agglutination in anti-fl-globulin serum and the adsorption of '31I-labeled anti-fl-globulin serum was related to the amount of C' globulin accumulated on the red cell surface (2) . Normal I-positive red cells, incubated with cold agglutinin and C' for several hours, adsorbed 131I-labeled anti-fl-globulin serum with the same avidity as the circulating cells of the patients. The resistance to C' hemolysis increased as C' complex accumulated.
The accumulation of C' globulins by the patient's cells was consistent with the demonstration that the cold agglutinins of all four patients had a thermal range of activity sufficient to cause attachment of C' globulins to red cells during incubation at 370C. Several other observations indicated that C' fixation by cold agglutinins occurred in the circulation at normal body temperature. An abrupt drop in serum C' level invariably followed the infusion of large volumes of red cells into two of the patients. In addition, there was evidence that the reaction with C' continued for some time after transfusion since it was several hours before all of the circulating red cells were again agglutinated by anti-fl-globulin serum. Further evidence for gradual accumulation of C' globulins in vivo was demonstrated in the development of resistance by the transfused red cells to C' hemolysis by cold agglutinin (Table V) red cells of E. M. were removed from the circulation of normal subjects at an accelerated rate. His red cells had developed a marked spherocytosis after splenectomy, suggesting that red cells which would have been removed by the spleen were allowed to remain in the circulation. The splenic filter mechanism has been shown to be particularly effective in removing spherocytic cells from the circulation in a variety of hemolytic states (10) (11) (12) .
The injection of normal red cells into the circulation of the three patients with chronic hemolytic anemia resulted in an initial phase of rapid removal followed by a second phase of more gradual destruction. The slope of the survival curve during the second phase was exponential and approximated the rate of removal of autologous red cells. The slower second phase of abnormal destruction was associated with the accumulation of C' complexes and the acquisition of resistance to C' hemolysis by the surviving red cells. Coating normal red cells from the same donor with C' complex by interaction with cold agglutinin and C' in vitro before injection produced slight to marked improvement in the survival during the first few hours. The disappearance was then exponential and also resembled the survival of autologous red cells. It appears from these data that red cells can be partially protected from the initial rapid phase of abnormal destruction in vivo by a coating of C' complex. Since all three patients had been transfused before our studies, it is possible that isoantibodies for red cells influenced the survival curves. It has been demonstrated that small quantities of 51Cr-labeled cells may be eliminated rapidly by isoantibodies that cannot be detected in vitro by available serological techniques (13) . In some instances of suspected isoimmunization a second injection of red cells from the same donor resulted in a normal survival; therefore, the improved survival of the C'1423-coated cells after the injection of normal cells does not entirely eliminate the possibility of isoimmunization (14) . However, it was demonstrated that a repeat injection of the normal red cells into A. J. after the improved survival of the C'1423-coated cells resulted in a typical biphasic curve of disappearance identical to the first survival curve. Furthermore, in separate observations with E. M. and A. J. administration of C'1423-coated cells before administration of normal red cells also resulted in improved survival of the C'1423 cells. The removal of normal 51Cr-labeled cells from different donors all followed a biphasic pattern which has been observed with some isoantibodies, most of which utilize C' (10) . Differences in rate of removal could be correlated with the amount of I antigen (Fig. 5) , and the second phase of slower removal of normal red cells which had become coated with C' approximated that of the patient's cells, suggesting that the same mechanism of removal was responsible.
It is of interest that red cells coated with C'1423 complex without acquiring resistance to C' hemolysis in vitro because of the reduced amounts of C' used in preparation were removed from the circulation almost as rapidly as normal red cells. It is not clear why coating with C' globulins by R3 serum failed to produce significant protection in vivo even though C' hemolysis in vitro was inhibited.
C' coating by cold agglutinin also influences the site of removal of red cells. In all three patients who received normal cells, counts accumulated in the liver during the initial rapid phase of removal of cells from the circulation. This finding is consistent with the concept that the normal red cells were susceptible to acute C' damage in vivo. Observations by Jandl and Kaplan (12) and by Cutbush and Mollison (10) have previously shown that cells subjected to sufficient damage by other C'-fixing red cell antibodies were removed at a rapid rate and principally by the liver.
Normal red cells that survived the acute phase of rapid destruction were then removed at a slower rate without predominance of either the liver or the spleen. The autologous red cells of cases 2 and 3 also failed to accumulate predominantly in either the liver or the spleen, which is in keeping with the observation of Lewis, Szur, and Dacie (15) . Only in the fourth patient, B. C., was there unequivocal evidence of splenic accumulation of autologous cells. It may be significant that the red cells of this patient had the shortest survival time with a tj of 7 days. Failure of organ accumulation of radioactivity in the other two patients may have been due to the less rapid rate of abnormal destruction so that accumulation of radioactivity from red cell destruction could have been balanced by loss of 51Cr by the organs (9) . / The survival studies of -normal red cells before and after transfusions in E. M. and A. J. indicate that the mechanism that removed cells rapidly had limitations and could be partially overwhelmed by large volumes of red cells. The fall in serum C' levels which followed the introduction of large volumes of red cells is the most obvious explanation of this partial suppression of the removal mechanism, since there was no reduction in cold agglutinin titer. Adsorption of an isoantibody by the large amount of transfused cells may be postulated to be a mechanism of improved survival of the second injection of 51Cr-labeled cells. Such a mechanism should have allowed a normal survival initially followed by rapid destruction as antibody reappeared, which is the opposite of what was observed. Temporary saturation of the reticuloendothelial tissue might have been a factor in the improved survival of labeled cells after transfusion. If this were the major factor, however, destruction of the damaged cells should have continued as reticuloendothelial tissue recovered. The survival curves in case 2 ( Fig. 5 ), particularly those with group A cells, suggested that no such suppression had occurred.
The destruction of red cells by cold agglutinins appears to be dependent on several variables, including the thermal range of the cold agglutinin, its C' fixing activity, the susceptibility of the red cells to C' damage, and the levels of serum C'. The syndrome presented by the four patients described in this report can occur if the cold agglutinins react with red cells at normal body temperature. The circulating red cells become coated with C' globulins and though still susceptible to agglutination by cold agglutinins are relatively resistant to acute damage by C'. Such patients have acrocyanosis from intravascular agglutination when chilled but may escape acute exacerbations of hemolysis. This mechanism appears insufficient to prevent intravascular hemolysis in all patients after they are chilled, since episodes of hemoglobinuria have been reported to occur in some (16, 17) .
